DavidRHassmanDO

PubMed

• 34 citations
  Evaluation of Potential Disease-Mediated Drug-Drug Interaction in Patients With Moderate-to-Severe Atopic Dermatitis Receiving Dupilumab.
  John D. Davis, Ashish Bansal, David Hassman, Bolanle Akinlade, Meng Li, Zhaoyang Li, Brian N. Swanson, Jennifer D. Hamilton, A. Thomas DiCioccio> ;Clinical Pharmacology and Therapeutics. 2018 Dec 1
• 5 citations
  Evaluation of a new safety peripheral IV catheter designed to reduce mucocutaneous blood exposure
  Rudy Onia, Ingrid Eshun-Wilson, Christina H. Arce, Christopher Ellis, Valentin Parvu, David Hassman, Kenneth Kassler-Taub> ;Current Medical Research and Opinion. 2011 Jun 15
• 31 citations
  Long-term effectiveness and tolerability of sublingual fentanyl orally disintegrating tablet for the treatment of breakthrough cancer pain.
  Srinivas Nalamachu, David Hassman, Mark S. Wallace, Sam Dumble, Rob Derrick, Julian Howell> ;Current Medical Research and Opinion. 2011 Feb 14
• 98 citations
  Efficacy and long-term tolerability of sublingual fentanyl orally disintegrating tablet in the treatment of breakthrough cancer pain
  Richard Rauck, Marvin Tark, Eva Reyes, Teresa G. Hayes, Anthony J Bartkowiak, David Hassman, Srinivas Nalamachu, Rob Derrick, Julian Howell> ;Current Medical Research and Opinion. 2009 Nov 16
• 32 citations
  Achieving low-density lipoprotein cholesterol goals in high-risk patients in managed care: comparison of rosuvastatin, atorvastatin, and simvastatin in the SOLAR trial.
  William Insull, Jalal K. Ghali, David R. Hassman, Joseph Ycas, Sanjay Gandhi, Elinor Miller> ;Mayo Clinic Proceedings. 2007 May 1
• 67 citations
  A multicenter, open-label, randomized, two-period crossover trial comparing glycemic control, satisfaction, and preference achieved with a 31 gauge x 6 mm needle versu...
  Sherwyn Schwartz, David R. Hassman, John Shelmet, Richard Sievers, Richard Weinstein, John Liang, William Lyness> ;Clinical Therapeutics. 2004 Oct 1
• 114 citations
  Repaglinide Versus Nateglinide Monotherapy: A randomized, multicenter study
  Julio Rosenstock, David R. Hassman, Robert D. Madder, Shari A. Brazinsky, James Farrell, Naum Khutoryansky, Paula M Hale> ;Diabetes Care. 2004 Jun 1
• 7 citations
  Patient perception and use of an insulin injector/glucose monitor combined device.
  Bruce W. Bode, John Shelmet, Brent Gooch, David R. Hassman, John Liang, Jorgen K. Smedegaard, Soren E. Skovlund, Birgitte Berg, William Lyness, Stephen H. Schneider> ;The Diabetes Educator. 2004 Mar 1
• 45 citations
  Treatment of type 2 diabetes with a combination regimen of repaglinide plus pioglitazone.
  Lois Jovanovic, David R. Hassman, Brent Gooch, Rajeev Jain, Susan Greco, Naum Khutoryansky, Paula M Hale> ;Diabetes Research and Clinical Practice. 2004 Feb 1
• 216 citations
  Efficacy and safety of ezetimibe coadministered with pravastatin in patients with primary hypercholesterolemia: a prospective, randomized, double-blind trial
  Lorenzo Melani, Richard Mills, David Hassman, Robert Lipetz, Leslie Lipka, Alexandre LeBeaut, Ramachandran Suresh, Pabak Mukhopadhyay, Enrico P. Veltri> ;European Heart Journal. 2003 Apr 1
• 131 citations
  Efficacy and safety of rosuvastatin compared with pravastatin and simvastatin in patients with hypercholesterolemia: a randomized, double-blind, 52-week trial.
  W.Virgil Brown, Harold E. Bays, David R. Hassman, James M. McKenney, Rohini Chitra, Howard Gerard Hutchinson, Elinor Miller> ;American Heart Journal. 2002 Dec 1
• Join now to see all